The Independent Market Observer

Looking Back at the Markets in January and Ahead to February 2022

Posted by Brad McMillan, CFA, CAIA, MAI

Find me on:

This entry was posted on Feb 8, 2022 1:10:06 PM

and tagged Commentary

Leave a comment

January saw a peak in medical and economic worries—and a turnaround. According to Commonwealth CIO Brad McMillan, the positive momentum should continue.January was a terrible month. Worries about economic damage from the Omicron wave were combined with the Fed’s perceived decision to start raising interest rates based on inflation levels at a 40-year high. Stocks were knocked down around the world. Tech stocks got hit especially hard, but even fixed income was down. It really was a terrible month.

Looking Back

Case growth spike. One of the major concerns was fear that the Omicron wave would derail the economy. Slowing job growth into the end of 2021 had already hit both confidence and consumer spending. The massive spike in new cases in January seemed to suggest the damage would only get worse.

Other reasons to worry. The other big worry was that inflation was still rising and had hit the highest level recorded since 1982. The Fed, already under fire for being behind the curve, signaled strongly that it would begin tightening monetary policy to get inflation under control—starting in March. With a combination of fears about slowing growth and the promise of higher interest rates, the significant market declines made sense.

Positive trends. In good news, the end of January also saw significant changes from the negative trends that knocked the markets earlier in the month. The Omicron wave peaked in mid-month and then started to drop sharply. Case growth ended the month down 40 percent from its peak two weeks earlier.

In February, so far, case growth has dropped another 20 percent from its January peak and looks to be on a steady and steep downward trajectory. If this trend holds, we should be back to the much-lower November 2021 infection levels by the end of this month. By the end of March, case growth should be close to its lows from last year, at or below the levels seen in the last Delta wave. So, January saw both the peak in medical risks—and the start of the turnaround.

Looking Ahead

Economy picking up. There is more good news. The other major concern, that the economy was weakening, was substantially reduced by the latest jobs report in early February. This release showed substantial job gains—much larger than had been previously reported—in November and December, along with much-larger-than-expected growth in January.

Not only did the economy not weaken during the Delta and Omicron waves, it actually picked up momentum. Looking forward, as that momentum combines with normalizing infection rates, we can reasonably expect economic growth to accelerate even further. In addition, confidence and spending should increase with employment. Again, January saw both a peak in worries about the labor market—and a turnaround.

Signals from the Fed. Where are we with the Fed? High inflation and the central bank’s plans to raise rates were a major worry in January, and there we have not seen a turnaround. High inflation rates are still very much with us. And the fact that employment is doing very well raises the chances the Fed will raise rates substantially. Still, looking forward, there are signs that inflation may be peaking. In several of the sectors with the highest price increases, such as used vehicles, the pressure is starting to moderate. There are also signs the Fed is trying to tamp down expectations for rate increases. So, although worries are still high, we might well see them pull back a bit in February.

Cushioned Volatility Likely Ahead

And that is the big picture. Looking back, our worries regarding medical, economic, inflation, and policy risks may have seen a peak in January. Since then, there have been clear signs that several of these risks have come down. Other, preliminary signs indicate the other risks will decline as well. In February, the markets will be sorting out these indicators and trying to figure out whether the risks are truly dropping and, if so, by how much. In other words, we can expect more volatility—but also more cushion under the markets and even the chance of a bounce.

January was a tough month, for good reason. February looks to be, if not a good month, at least one that is less bad. Despite the risks that are still out there, the potential for a good month is very real. In any event, we should see better news overall.


Subscribe via Email

Crash-Test Investing

Hot Topics



New Call-to-action

Conversations

Archives

see all

Subscribe


Disclosure

The information on this website is intended for informational/educational purposes only and should not be construed as investment advice, a solicitation, or a recommendation to buy or sell any security or investment product. Please contact your financial professional for more information specific to your situation.

Certain sections of this commentary contain forward-looking statements that are based on our reasonable expectations, estimates, projections, and assumptions. Forward-looking statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Past performance is not indicative of future results. Diversification does not assure a profit or protect against loss in declining markets.

The S&P 500 Index is a broad-based measurement of changes in stock market conditions based on the average performance of 500 widely held common stocks. All indices are unmanaged and investors cannot invest directly in an index.

The MSCI EAFE (Europe, Australia, Far East) Index is a free float‐adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the U.S. and Canada. The MSCI EAFE Index consists of 21 developed market country indices.

One basis point (bp) is equal to 1/100th of 1 percent, or 0.01 percent.

Third-party links are provided to you as a courtesy. We make no representation as to the completeness or accuracy of information provided on these websites. Information on such sites, including third-party links contained within, should not be construed as an endorsement or adoption by Commonwealth of any kind. You should consult with a financial advisor regarding your specific situation.

Member FINRASIPC

Please review our Terms of Use

Commonwealth Financial Network®